Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3685
+0.0014 (0.38%)
At close: Jul 1, 2025, 4:00 PM
0.3661
-0.0024 (-0.65%)
After-hours: Jul 1, 2025, 7:15 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $21.83 million as of July 1, 2025. Its market cap has decreased by -88.11% in one year.
Market Cap
21.83M
Enterprise Value
-27.58M
1-Year Change
-88.11%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $21.83M, a decrease of -94.02%. That is a compound annual growth rate of -50.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 21.75M | -34.60% |
| Dec 31, 2024 | 33.26M | 46.03% |
| Dec 29, 2023 | 22.78M | 2.97% |
| Dec 30, 2022 | 22.12M | -84.16% |
| Dec 31, 2021 | 139.65M | -61.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.10B |